Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
These results, combined with orforgliprons once-daily oral dosing and broad scalability, reinforce its potential as a foundational treatment for type 2 diabetes. Eli Lilly also recently presented detailed results from the ATTAIN-1 trial, which investigated orforglipron in adults with obesity or overweight without diabetes, at the European Association for the Study of Diabetes (EASD) Annual Meeting 2025
A 2020 study in Nutrients found that hydrolyzed collagen peptides stimulated GLP-1 secretion in human enteroendocrine cells
:format(webp))
As someone who has experienced the transformative impact of effective obesity treatment, I urge policymakers to act
J Toxicol Environ Health
Iacobellis G, Willens HJ
doi:10.3389/fphar.2022.935823
US$ 27.45
US$ 20.47
US$ 27.74
US$ 23.14
US$ 20.83
